Differential cytotoxic effects of mizoribine and its aglycone on human and murine cells and on normal and enzyme-deficient human cells

This publication has 13 references indexed in Scilit:

• Guanine ribonucleotide depletion inhibits T cell activation. Mechanism of action of the immunosuppressive drug mizoribine.
  Journal of Clinical Investigation, 1991
• Clinical effectiveness of mizoribine on rheumatoid arthritis. A duoble-blind comparative study using lobenzarit disodium as a standard drug.
  Ensho, 1991
• Dual inhibitory effect of bredinin
  Cell Biochemistry and Function, 1989
• Distribution of Patients with 2,8-Dihydroxyadenine Urolithiasis and Adenine Phosphoribosyltransferase Deficiency in Japan
  Journal of Urology, 1988
• SYNERGISTIC EFFECT OF CYCLOSPORINE AND MIZORIBINE ON SURVIVAL OF DOG RENAL ALLOGRAFTS
  Transplantation, 1988
• Application of Mizoribine After Keratoplasty and in the Treatment of Uveitis
  American Journal of Ophthalmology, 1985
• Effect of mizoribine on lupus nephropathy of New Zealand black/white F1 hybrid mice
  Clinical Immunology and Immunopathology, 1984
• BREDININ TREATMENT IN CLINICAL KIDNEY ALLOGRAFTING
  Transplantation, 1984
• Genetic and biochemical studies on the activation and cytotoxic mechanism of bredinin, a potent inhibitor of purine biosynthesis in mammalian cells
  Biochemical Pharmacology, 1983
• Studies on bredinin. I. Isolation, characterization and biological properties.
  The Journal of Antibiotics, 1974